Kepler Cheuvreux Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Buy
Tweet Send to a Friend
Kepler Cheuvreux analyst Nicolas Pauillac upgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Hold to Buy with a price target of GBP25.16 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
